Octreotide acetate (Wockhardt USA LLC.)
Welcome to the PulseAid listing for the Octreotide acetate drug offered from Wockhardt USA LLC.. This Somatostatin Analog [EPC],Somatostatin Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Wockhardt USA LLC. |
NON-PROPRIETARY NAME: | Octreotide acetate |
SUBSTANCE NAME: | OCTREOTIDE ACETATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Somatostatin Analog [EPC],Somatostatin Receptor Agonists [MoA] |
ROUTE: | INTRAVENOUS; SUBCUTANEOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2011-05-11 |
END MARKETING DATE: | 0000-00-00 |
Octreotide acetate HUMAN PRESCRIPTION DRUG Details:
Item Description | Octreotide acetate from Wockhardt USA LLC. |
LABELER NAME: | Wockhardt USA LLC. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1000(ug/mL) |
START MARKETING DATE: | 2011-05-11 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 64679-632_ef0b005f-898a-4944-a983-72fe170ab7c7 |
PRODUCT NDC: | 64679-632 |
APPLICATION NUMBER: | ANDA090986 |
Other OCTREOTIDE ACETATE Pharmaceutical Manufacturers / Labelers: